AIDS Treatment News - 2004

• AIDS Treatment News - 2004
• Issue #398
• Antiretroviral Pipeline: New-Drug Reports from Retroviruses Conference
• FDA Advisory Hearing on New-Fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland
• Lipodystrophy: Conference on Imaging Technologies in Clinical Management, Montreal, April 2-3, 2004
• Micronutrient Supplementation Shows Promise in Placebo-Controlled Trial
• Nevirapine Precautions Published
• Prison HIV and Hepatitis C Sites
• "Poppers," Some Other Drugs, May Increase HIV Infection Risk
• New Testing for Very Early HIV Diagnosis
• No January 2004 Issue of AIDS Treatment News
• Improving AIDS Conferences with Online Information


• Issue #399
• Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
• Atherosclerosis Risk Increased with HIV; Treatment Effects Unclear
• Atazanavir (Reyataz): New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
• Abacavir Hypersensitivity Reaction Predicted by Genetic Test
• Update on Sculptra (New-Fill) Hearing
• Lessons from Two
• Retroviruses Conference: Summaries for Physicians
• Medicines for the World: A Way Forward


• Issue #400
• TMC125: Important One-Year Trial Now Recruiting in U.S.
• Gonorrhea: New Treatment Recommendations for Gay Men, MSM
• May 20
• How to Network Action Alerts, So That Others Can Help
• Online Glossaries of HIV/AIDS Terms
• Checking Your Drug Interactions
• Inexpensive Air Filter for Allergy Relief


• Issue #401
• New Medicare-Approved Prescription Drug Discount Card
• Institute of Medicine Urges Restructuring of U.S. Low-Income HIV Treatment and Care
• ADAP Crisis National Call-In Alert, Starting June 14
• Grants for Innovative Treatment, Vaccine, or Microbicide Research, Application Deadline July 31
• Bangkok AIDS Conference May Be Largest Ever, July 11 to 16
• Ronald Reagan Remembered


• Issue #402
• Bangkok Conference, July 11-16; Getting News Online
• U.S. Researcher Starts Treatment Fund in Uganda: Interview with David Bangsberg, M.D., M.P.H.
• President Bush on AIDS: More Questions Than Answers
• Abstinence, Abstinence-Only, Faith-Based, and the Psychology of Stigma
• Medical Marijuana: Important Vote Coming, You Can Help
• ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
• Drug Resistance Workshop (June 2004) Summaries Available


• Issue #403
• Chronically Depressed Women with HIV Almost Twice As Likely As Others to Die from AIDS-Related Causes; Those with Mental-Health Services Had Half the Death Rate of Those Without
• Cambodia Stops Important Tenofovir Prevention Trial
• Hepatitis Coinfection: Two Major Studies Published
• FDA Approves Two Combination Pills, Epzicom and Truvada; Comment on Commercial Race to Once-a-Day Nucleosides
• Smarter Clinical Trials for Faster Drug Development
• Retroviruses Conference Date Set
• HIV Treatment and Immunology Research: Current Ideas


• Issue #404
• ADAP Activists Needed in All U.S. States and Territories
• ACT UP: Enormous Worldwide Attention to New York Demos
• Medical Information from Bangkok Conference: Clinical Care Options Site
• AIDSVote: Election Information and Activism
• Elections: Widespread Misinformation on Who Can Vote
• Nutrition: Call for Information -- What Has Been Most Helpful to You?
• Medical Marijuana Rescheduling Rally, Washington DC October 5
• Empty Antibiotic Pipeline Critically Endangers Public: IDSA Report
• Clinical Trials: Philadelphia Hospitals Combine to Form "Supersite" and Reduce Delays
• AIDS Treatment and Related Conference Calendar (Starting September 2004)


• Issue #405
• Depression: Louganis and Allen to Speak at Forums in New York, and San Francisco Oct. 27
• New Fixed-Dose Once-a-Day Starting Regimens: Interview with Cal Cohen, M.D.
• Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
• Kaletra Monotherapy Controversy: AmfAR Publishes Overview
• Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004


• Issue #406
• Saving AIDS Conferences Online: Interview with Sister Mary Elizabeth, Founder of AEGiS
• Warning on Two Specific 3-Drug Regimens: Viread + Didanosine + Either Sustiva or Viramune
• New Treatment Guidelines Published October 29
• Retroviruses Conference: Community Deadlines, Nov. 23
• World AIDS Day, December 1: Women and Girls
• Prison Health Care: Activist Campaign Targets Hepatitis, HIV Care for Prisoners, and Continuity of Care After Release
• After the Election


• Issue #407
• Weekend Treatment Interruptions for Certain Well-Controlled Patients: Interview with Cal Cohen, M.D.
• Sculptra (Formerly New Fill) for Facial Wasting -- Where to Find Information on the Patient-Assistance Program
• Nevirapine Misinformation: Will It Kill?
• Missing Conferences Followup: Four Meetings' History Found
• Buyers' Club List, December 2004
• AIDS Treatment News Index, 2004


• Issue #408
• Behind "AIDS Breakthrough" Headlines, December 2004: Important Research, Not So New
• Warning: Do Not Combine Reyataz and Prilosec
• Treatment Interruption: Most Patients Could Not Maintain Immune Control
• India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries
• Africa: Children’s Access to Prophylaxis May Improve After Medical Study, New WHO Recommendations
• Retroviruses Conference Reminder: You Must Complete Housing Process to Attend


• Behind "AIDS Breakthrough" Headlines, December 2004: Important Research, Not So New
• Warning: Do Not Combine Reyataz and Prilosec
• India Changes Patent Law to Meet WTO Treaty, Making New Medicines Less Available to Most Citizens, Other Countries
• Africa: Children's Access to Prophylaxis May Improve After Medical Study, New WHO Recommendations
• Treatment Interruption: Most Patients Could Not Maintain Immune Control
• Retroviruses Conference Reminder: You Must Complete Housing Process to Attend
• Weekend Treatment Interruptions for Certain Well-Controlled Patients: Interview with Cal Cohen, M.D.
• Sculptra (Formerly New Fill) for Facial Wasting -- Where to Find Information on Patient-Assistance Program
• Missing Conferences Followup: Four Meetings' History Found
• Buyers' Club List, December 2004
• Nevirapine Misinformation: Will It Kill?
• Saving AIDS Conferences Online: Interview with Sister Mary Elizabeth, Founder of AEGiS
• Warning on Two Specific 3-Drug Regimens: Viread + Videx + Either Sustiva or Viramune
• New Treatment Guidelines Published October 29
• Retroviruses Conference: Community Deadlines, Nov. 23
• World AIDS Day, December 1: Women and Girls
• Prison Health Care: Activist Campaign Targets Hepatitis, HIV Care for Prisoners, and Continuity of Care After Release
• After the Election
• New Fixed-Dose Once-a-Day Starting Regimens: Interview with Cal Cohen, M.D.
• Depression: Louganis and Allen Speak at Forum in New York, and in San Francisco Oct. 27
• Warning Against Using Erythromycin (Even Orally) While Using Protease Inhibitors or Certain Other Drugs
• Kaletra Monotherapy Controversy: AmfAR Publishes Overview
• Access to NIH-Funded Research Information -- Public Comment Period to November 16, 2004
• ADAP Activists Needed in All U.S. States and Territories
• ACT UP: Enormous Worldwide Attention to New York Demos
• Medical Information from Bangkok Conference: Clinical Care Options Site
• AIDSVote: Election Information and Activism
• Elections: Widespread Misinformation on Who Can Vote
• Nutrition: Call for Information -- What Has Been Most Helpful to You?
• Medical Marijuana Rescheduling Rally, Washington DC October 5
• Empty Antibiotic Pipeline Critically Endangers Public: IDSA Report
• Clinical Trials: Philadelphia Hospitals Combine to Form "Supersite" and Reduce Delays
• AIDS Treatment and Related Conference Calendar (Starting September 2004)
• Chronically Depressed Women with HIV Almost Twice As Likely As Others to Die from AIDS-Related Causes; Those with Mental-Health Services Had Half the Death Rate of Those Without
• Cambodia Stops Important Tenofovir Prevention Trial
• Hepatitis Coinfection: Two Major Studies Published
• FDA Approves Two Combination Pills, Epzicom and Truvada; Comment on Commercial Race to Once-a-Day Nucleosides
• Smarter Clinical Trials for Faster Drug Development
• Retroviruses Conference Date Set
• HIV Treatment and Immunology Research: Current Ideas
• Bangkok Conference, July 11-16; Getting News Online
• U.S. Researcher Starts Treatment Fund in Uganda: Interview with David Bangsberg, M.D., M.P.H.
• President Bush on AIDS: More Questions Than Answers
• Abstinence, Abstinence-Only, Faith-Based, and the Psychology of Stigma
• Medical Marijuana: Important Vote Coming, You Can Help
• ADVAX, New DNA Vaccine in Human Trial; HIV-Negative Volunteers Needed in New York City or Rochester, NY Areas
• Drug Resistance Workshop (June 2004) Summaries Available
• New Medicare-Approved Prescription Drug Discount Card
• Institute of Medicine Urges Restructuring of U.S. Low-Income HIV Treatment and Care
• ADAP Crisis National Call-In Alert, Starting June 14
• Inexpensive Air Filter for Allergy Relief
• Grants for Innovative Treatment, Vaccine, or Microbicide Research, Application Deadline July 31
• Bangkok AIDS Conference May Be Largest Ever, July 11 to 16
• Ronald Reagan Remembered
• TMC125: Important One-Year Trial Now Recruiting in U.S.
• Gonorrhea: New Treatment Recommendations for Gay Men, MSM
• May 20 "Time's Up!" AIDS Protest in Washington D.C.
• How to Network Action Alerts, So That Others Can Help
• Online Glossaries of HIV/AIDS Terms
• Checking Your Drug Interactions
• Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
• Atherosclerosis Risk Increased with HIV; Treatment Effects Unclear
• Abacavir Hypersensitivity Reaction Predicted by Genetic Test
• Update on Sculptra (New-Fill) Hearing
• Lessons from Two "Triple Nuke" Failures (New Training Module)
• Retroviruses Conference: Summaries for Physicians
• Medicines for the World: A Way Forward
• Atazanavir (Reyataz) New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
• Action Alerts: Please Improve Them for Networking
• FDA Advisory Hearing on New-Fill (Sculptra), March 25, 2004 in Gaithersburg, Maryland
• Antiretroviral Pipeline: New-Drug Reports from Retroviruses Conference
• Nevirapine Precautions Published
• Micronutrient Supplementation Shows Promise in Placebo-Controlled Trial
• Lipodystrophy: Conference on Imaging Technologies in Clinical Management, Montreal, April 2-3, 2004
• "Poppers," Some Other Drugs, May Increase HIV Infection Risk
• New Testing for Very Early HIV Diagnosis
• Improving AIDS Conferences with Online Information
• Institute of Medicine Calls for Universal Health Insurance by 2010
• Greg Smith in prison
• Greg Smith funeral demonstration at sentencing judge's home
• Remembering Greg Smith

All information on AIDS.ORG is designed to support, but not replace your relationship with your doctor, and is intended soley for educational or research purposes. Any and all personal information you may provide us with is never released to anyone at any time. Your privacy and trust is extremely important to us.

• News
• Topics
• Experience
• Donate
• About Us

• Headlines
• AIDS Treatment News